Stay updated on Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.

Latest updates to the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.8.1 instead of v3.8.0; the study record content remains unchanged.SummaryDifference0.1%

- Check12 days agoChange DetectedThe clinical-trial record for the completed Phase 1 ABBV-951 study is now displayed, with details about its Parkinson’s disease research, participant criteria, study locations, treatment arms, and measured outcomes.SummaryDifference52%

- Check19 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedA banner was added announcing NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence.” The site revision number was updated from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating an access restriction or server issue that prevents loading the study record.SummaryDifference18%

Stay in the know with updates to Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.